The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer

• Published in: Gynecologic oncology 2022-07, Vol.166 (1), p.8-17
• Main Authors: Angeles, Martina Aida, Hernández, Alicia, Pérez-Benavente, Asunción, Cabarrou, Bastien, Spagnolo, Emanuela, Rychlik, Agnieszka, Daboussi, Amel, Migliorelli, Federico, Bétrian, Sarah, Ferron, Gwénaël, Gil-Moreno, Antonio, Guyon, Frédéric, Martinez, Alejandra
• Format: Article
• Language: English
• Subjects: Advanced epithelial ovarian cancer; Debulking surgery; Neoadjuvant chemotherapy; Peritoneal carcinomatosis; Postoperative complications; Surgical morbidity
• ISSN: 0090-8258; 1095-6859
• DOI: 10.1016/j.ygyno.2022.05.002

To assess the impact on survival of major postoperative complications and to identify the factors associated with these complications in patients with advanced ovarian cancer after cytoreductive surgery. We designed a retrospective multicenter study collecting data from patients with IIIC-IV FIGO Stage ovarian cancer who had undergone either primary debulking surgery (PDS), early interval debulking surgery (IDS) after 3–4 cycles of neoadjuvant chemotherapy, or delayed debulking surgery (DDS) after 6 cycles, with minimal or no residual disease, from January 2008 to December 2015. Univariable and multivariable analyses were conducted to identify factors associated with major surgical complications (≥Grade 3). We assessed disease-free survival (DFS) and overall survival (OS) rates according to the occurrence of major postoperative complications. 549 women were included. The overall rate of major surgical complications was 22.4%. Patients who underwent PDS had a higher rate of major complications (28.6%) than patients who underwent either early IDS (23.2%) or DDS (14.0%). Multivariable analysis revealed that extensive peritonectomy and surgical timing were associated with the occurrence of major complications. Median DFS and OS were 16.9 months (95%CI = [13.7–18.4]) and 48.0 months (95%CI = [37.2–73.1]) for the group of patients with major complications, and 20.1 months (95%CI = [18.6–22.4]) and 56.7 months (95%CI = [51.2–70.4]) for the group without major complications. Multivariable analysis revealed that major surgical complications were significantly associated with DFS, but not with OS. Patients who experienced major surgical complications had reduced DFS, compared with patients without major morbidity. Extensive peritonectomy and surgical timing were predictive factors of postoperative morbidity. •Major surgical complications have a negative impact on patients' disease-free survival•Major postoperative complications hinder the delivery of adjuvant chemotherapy•Extensive peritonectomy and surgical timing are linked to major postoperative morbidity